Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05098366Phase 1Completed
Phase 1, randomised, single-blind trial of furosemide (2 arms), sponsored by Connecticut Children's Medical Center. Primary endpoint: Time from initiation of intervention to large, ovoid bladder on POCUS at 3 hours. Started May 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05098366.